Tag: Localization

Belarus will help to organize pharma manufacturing in Tajikistan

By the end of this year, Belarus and Tajikistan may elaborate a roadmap to establish joint ventures in the pharmaceutical industry, announced Oleg Ivanov, the Ambassador of Belarus in Tajikistan and Afghanistan.

Servier and the Government of Kazakhstan agreed on cooperation

Servier, a French pharmaceutical company, and National Company KAZAKH INVEST JSC have signed an agreement on cooperation in the area of pharmaceutical manufacturing.

Kirov pharma cluster participants explored biotech development in France

The delegation of the government of the Kirov region visited the Lyonbiopôle in France, which is largest pharmaceutical cluster in the world.

AbbVie and R-Pharm will launch the full-cycle manufacturing of Kaletra in Russia

AbbVie, a global research biopharmaceutical company, and R-Pharm Group announced the completion of technology transfer for manufacturing Kaletra intended for treatment of HIV/AIDS infection in adult patients.

French company will set up a production of innovative medicines in Kazakhstan

At the meeting on global investments held in Astana, the companies of Kazakhstan signed 32 commercial documents for the total amount of $4.7 billion.

ABISS intends to localize manufacturing of medical devices in Russia

ABISS, the French company, a manufacturer of implants, together with the Federal Corporation for the Development of Small and Medium Enterprises, prepared a "road map" for manufacturing localization of its products in Russia.

AVVA RUS invites for cooperation in the area of contract manufacturing

The company is ready to help both Russian developers to enter international markets and international companies to localize their products in Russia.

Bayer plans to increase the share of its localized products in Russia

Bayer intends to raise the share of its localized products in Russia to 30% of the total sales. The company is already implementing a number of large-scale projects to localize the manufacturing of innovative medicines

Russia will support pharmaceutical manufacturers with high level of localization

Russian Prime Minister Dmitry Medvedev signed the Decree No. 572 of May 12, 2018, aimed at supporting the manufacturers of medicinal products that perform all stages of production.

Today’s realities in the development of local and contract manufacturing

The representatives of pharmaceutical companies met at the forum of the Adam Smith Institute where they shared their views on the development of local and contract manufacturing.

Kaluga pharmaceutical cluster shows growth and increase in localization level

According to the Governor of Kaluga region Anatoly Artamonov, Kaluga pharmaceutical cluster achieved significant results over the seven years of its existence.

Abbott localized full-cycle manufacturing of its drug at the Veropharm plant

Abbott presented a new production line to localize the full-cycle manufacturing of an Abbott drug to support women's reproductive health, which is in line with the strategic objectives of the government in Russia.

Moscow plans to further develop offset agreement mechanism

drug development
Offset agreements are a new effective mechanism for public procurement, in which the supplier agrees to establish or upgrade a production facility within the city, while the city authorities agree to purchase the products.

Milan hosted a convention of the Russian-Italian subgroup for pharma industry

A delegation of the Russian Ministry of Industry and Trade lead by the Head of the Department of Pharmaceutical and Medical Industry Development – arrived in Italy with a mission to support cooperation between the countries.

Takeda Russia launches a combined sugar-lowering drug

Takeda, a pharmaceutical company, has developed an innovative sugar-lowering drug that is a combination of alogliptin and metformin. The representatives of the company announced that the drug was launched in the Russian market.

MSD and AKRIKHIN localized manufacturing of sitagliptin in Russia

MSD, an innovative global pharmaceutical company, and AKRIKHIN, a leading Russian pharmaceutical manufacturer, announced the successful localization of 100 mg finished dosage form of sitagliptin.